Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review

Over-the-Counter (OTC) Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment (MCI), and Clinical Alzheimer-Type Dementia: A Systematic Review is organized by American College of Physicians (ACP) and will be held during Apr 23, 2018 - Dec 19, 2020. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits and MOC Points.

Course Description:
Optimal interventions to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia are uncertain. The purpose of this systematic review is to summarize the evidence on efficacy and harms of over-the-counter (OTC) supplements to prevent or delay cognitive decline, MCI, or clinical Alzheimer-type dementia in adults with normal cognition or MCI but no dementia diagnosis.

Additional details will be posted as soon as they are available.